2016 Program

Sun, 11/13

5:00 PM – 7:00 PM

Mon, 11/14

7:30 AM – 8:30 AM
8:30 AM – 8:45 AM
8:45 AM – 9:00 AM
Time=Lives Talk
  • Eleanor Perfetto
    Senior Vice President, Strategic Initiatives, National Health Council
9:00 AM – 10:15 AM
Plenary - More than a Seat at the Table: Creating a Culture of Patient Engagement
  • Deborah Brooks
    Co-Founder and Executive Vice Chairman, The Michael J. Fox Foundation for Parkinson's Research
  • Julie Fleshman
    President and CEO, Pancreatic Cancer Action Network
  • Julie Gerberding
    Executive Vice President & Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health, Merck & Co, Inc.
  • Adrian Hernandez
    Professor of Medicine, Cardiology, Duke University School of Medicine
10:30 AM – 11:45 AM
Panel - From Avalanche to Aha! Successes in Collecting Patient Data for Research
  • Gina Agiostratidou
    Program Director, T1D, Helmsley Charitable Trust
  • Ray Dorsey
    David M. Levy Professor, Neurology; Director, Center for Human Experimental Therapeutics, University of Rochester Medical Center
  • Joel Dudley
    Director, Next Generation Healthcare Institute, Associate Professor, Genetics and Genomic Sciences, Icahn School of Medicine, Mount Sinai
  • Noga Leviner
    Co-Founder and CEO, PicnicHealth
  • Sally Okun
    Vice President for Advocacy, Policy and Patient Safety, PatientsLikeMe
Panel - Mixing Policy and Politics: Opportunities and Challenges for our President-Elect
  • Dan Diamond
    Author, Politico Pulse

  • Kay Holcombe
    Senior Vice President, Science Policy, Biotechnology Innovation Organization (BIO)
  • Andrew von Eschenbach
    President, Samaritan Health Initiatives Inc.; former Commissioner, U.S. Food and Drug Administration; former Director, National Cancer Institute
  • Keith Yamamoto
    Vice Chancellor for Science Policy and Strategy; Executive Vice Dean, School of Medicine; Professor, Cellular & Molecular Pharmacology, University of California, San Francisco
Workshop - Challenge Accepted: Data Science Solutions to Accelerate Medical Research
  • John Wilbanks
    Chief Commons Officer, Sage Bionetworks

  • Russ Altman
    Professor, Bioengineering, Genetics and Medicine; Former Chair, Bioengineering, Stanford University
  • Leslie Fine
    VP, Product, Data and Analytics, Salesforce
  • Rachel Kalmar
    Fellow, Berkman Klein Center for Internet & Society at Harvard University
11:45 AM – 12:15 PM
12:15 PM – 12:45 PM
12:45 PM – 1:15 PM
1:15 PM – 2:30 PM
Plenary - Making Waves: Trends and Technologies Transforming Health and Research
  • Aneesh Chopra
    Co-Founder and Executive Vice President, Hunch Analytics

  • James Hamblin
    Senior Editor, The Atlantic
  • Dan Mendelson
    President, Avalere Health
2:45 PM – 4:00 PM
Panel - Backing the Next Breakthrough: New Models for Investing in Biomedicine
  • Court Coursey
    Managing Partner, TomorrowVentures

  • Aron Betru
    Managing Director, Center for Financial Markets, Milken Institute
  • Lindy Fishburne
    Founder, Breakout Labs, Thiel Foundation; Managing Partner, Breakout Ventures
  • Peter Schultz
    CEO, The Scripps Research Institute; President, California Institute for Biomedical Research
  • David Steinberg
    Executive Vice President, PureTech
Panel - Tools of Engagement: How Patient-Centricity Can Advance Product Development
  • Karen Rogers
    Associate Director, Communications, FasterCures

  • Pamela Bradt
    Executive Medical Director for Urology, Astellas Pharma Global Development, Inc.
  • Ron Cohen
    President and CEO, Acorda Therapeutics, Inc.; Chair, Biotechnology Innovation Organization
  • Bradford Hirsch
    Senior Medical Director, Flatiron Health
  • Kim McCleary
    Managing Director, FasterCures
  • Suzanne Schrandt
    Director, Patient Engagement, Arthritis Foundation
Workshop - Who Tells Their Story? Determining Value from the Patient Perspective
  • Josh Seidman
    Senior Vice President, Avalere Health

  • Madeleine Konig
    Senior Policy Analyst, American Heart Association
  • Jean Moody-Williams
    Deputy Director, Center for Clinical Standards and Quality, Centers for Medicaid and Medicare Services
  • Martin Zagari
    Vice President, Global Health Economics, Amgen
4:00 PM – 5:00 PM
5:00 PM – 7:00 PM

Tue, 11/15

7:30 AM – 8:30 AM
8:30 AM – 8:45 AM
8:45 AM – 9:00 AM
9:00 AM – 10:15 AM
Plenary - New Frontiers in Preventive Medicine: From Faster Cures to Faster Health
  • Margaret Anderson
    Executive Director, FasterCures

  • Esther Dyson
    Founder, Way to Wellville
  • Michael Milken
    Chairman, Milken Institute; Founder, FasterCures
  • Joe Selby
    Executive Director, Patient-Centered Outcomes Research Institute
10:30 AM – 11:45 AM
Panel - Clinical Trial Master Protocols: Is It the Wild, Wild West Out There?
  • Anna Barker
    Professor and Director, Transformative Healthcare Networks; Co-Director, Complex Adaptive Systems Network, Arizona State University

  • Brian Alexander
    Disease Center Lead, Center for Neuro-Oncology, Dana-Farber Cancer Institute
  • Jeff Allen
    President and CEO, Friends of Cancer Research
Panel - R&D Remodel: Building Trust and Changing the Culture in Research
  • Kathy Hudson
    Deputy Director for Science, Outreach, and Policy, National Institutes of Health

  • Jason Bobe
    Executive Director, PersonalGenomes.org; Associate Professor and Director, Sharing Lab, Icahn Institute for Genomics and Multiscale Biology, Mount Sinai School of Medicine
  • Matthias Evers
    Senior Partner, McKinsey & Company
  • Allan Jones
    Chief Executive Officer, Allen Institute
  • Richard Pops
    Chairman and CEO, Alkermes
  • Kaitlin Thaney
    Director, Mozilla Leadership Networks
Workshop - Patients in the Driver's Seat: Precision Medicine and Direct-to-Patient R&D
  • Elizabeth Cohn
    Associate Director, Community Engagement Core Resource, Irving Institute for Clinical and Translational Science, Columbia University
  • Stephanie Devaney
    Project Manager, Precision Medicine Initiative
  • Kathy Giusti
    Founder, Multiple Myeloma Research Foundation; Faculty Co-Chair, Harvard Business School Kraft Precision Medicine Accelerator
  • Juergen Klenk
    Principal, Deloitte Consulting LLP
11:45 AM – 12:15 PM
12:15 PM – 12:45 PM
1:15 PM – 2:30 PM
Plenary - Big Science: Does More Mean a Better Future?
  • Francis Collins
    Director, National Institutes of Health

  • Atul Butte
    Director, Institute of Computational Health Sciences, and Professor of Pediatrics, University of California, San Francisco
  • Robert Califf
    Commissioner, U.S. Food and Drug Administration
  • Greg Simon
    Executive Director of the Cancer Moonshot Taskforce, Office of the Vice President, The White House
  • Sonia Vallabh
    Co-Founder, Prion Alliance; Researcher, Broad Institute